SynthesisFrontiers in immunology2026

PD-1/PD-L1 inhibitors combined with chemotherapy or as monotherapy versus chemotherapy alone or observation in triple-negative breast cancer: a systematic review and updated meta-analysis incorporating long-term survival data.

Bing Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.